Michael D. Wyzga - Aug 16, 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KA)

Role
Sr. VP & Chief Financial Officer
Signature
/s/ Marie Epstein, Attorney-in-Fact
Stock symbol
KA
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
4
Date filed
8/17/2021, 05:22 PM
Next filing
Dec 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award $0 +65K $0.00 65K Aug 16, 2021 Common Stock 65K $9.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on August 16, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years.

Remarks:

Sr. VP & Chief Financial Officer